Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Denis Campbell Health policy editor

Hope for thousands as NHS approves drug for acute migraine

Model of human head with glowing spot
About one in seven people in the UK experience migraine. Photograph: Ilya Lukichev/Getty Images/iStockphoto

NHS health advisers have approved the first treatment for acute migraine in a decision that promises to bring relief to about 13,000 people.

The National Institute of Health and Clinical Excellence (Nice) has recommended a drug called rimegepant, also known as Vydura, which is made by Pfizer.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.